All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Regeneron Pharmaceuticals, Inc. market cap

Regeneron Pharmaceuticals, Inc. volume of trade today and historical data of Regeneron Pharmaceuticals, Inc. capitalization since start date of trade of REGN stocks.
Add to widgets
Added to widgets

Regeneron Pharmaceuticals, Inc. capitalization

Today's market capitalization for Regeneron Pharmaceuticals, Inc. is 63 916 994 560 US dollar.
+794 406 912 $ (+1.26%)
change of capitalization since yesterday

Regeneron Pharmaceuticals, Inc. capitalization online today in dollars. Regeneron Pharmaceuticals, Inc. capitalization is open information. You can find out the Regeneron Pharmaceuticals, Inc. capitalization for today based on the trading of this stock quote on stock exchange market. The value of all Regeneron Pharmaceuticals, Inc. stocks issued (Regeneron Pharmaceuticals, Inc. market cap) increased by $ 794 406 912.

Regeneron Pharmaceuticals, Inc. volume of trade

Today's Regeneron Pharmaceuticals, Inc. volume of trade is 339 909 US dollar.
-472 833 $ (-58.18%)
change of volume of trade since yesterday

Regeneron Pharmaceuticals, Inc. trading volume today is 339 909 US dollars. The daily chart of the Regeneron Pharmaceuticals, Inc. trading volume is presented on our website. Regeneron Pharmaceuticals, Inc. trading helds on many stock quote exchanges in real time, we show the daily trading volume of Regeneron Pharmaceuticals, Inc.. Regeneron Pharmaceuticals, Inc. market cap was lower yesterday.

Show:
to

Regeneron Pharmaceuticals, Inc. market cap chart

Regeneron Pharmaceuticals, Inc. market cap chart by years. 2.6% - a change in the market capitalization of Regeneron Pharmaceuticals, Inc. per month. 94.06% per year - a change in the market capitalization of Regeneron Pharmaceuticals, Inc.. The market capitalization of Regeneron Pharmaceuticals, Inc. is now equal to 63 916 994 560 US dollars.

Week Month 3 months Year 3 years

Regeneron Pharmaceuticals, Inc. capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
22/05/2020 63 916 994 560 $
21/05/2020 63 122 587 648 $
20/05/2020 64 912 818 176 $
19/05/2020 63 780 847 616 $
18/05/2020 63 043 829 760 $
15/05/2020 64 893 685 760 $
14/05/2020 64 110 534 656 $

Regeneron Pharmaceuticals, Inc. volume chart

Week Month 3 months Year 3 years

Regeneron Pharmaceuticals, Inc. volume history data

Date Volume (24h)
Volume of trade of Regeneron Pharmaceuticals, Inc. - total sum in US dollars for all deals with REGN stocks bought and sold during selected date.
22/05/2020 339 909 $
21/05/2020 812 742 $
20/05/2020 792 254 $
19/05/2020 162 382 $
18/05/2020 951 457 $
15/05/2020 697 990 $
14/05/2020 404 708 $

Regeneron Pharmaceuticals, Inc. market capitalization in US dollars today 22/05/2020. 21/05/2020 Regeneron Pharmaceuticals, Inc. capitalization is equal to 63 122 587 648 US dollars. 20/05/2020 Regeneron Pharmaceuticals, Inc. market capitalization is equal to 64 912 818 176 US dollars. Regeneron Pharmaceuticals, Inc. capitalization at 19/05/2020 amounted to 63 780 847 616 US dollars.

Regeneron Pharmaceuticals, Inc. capitalization at 18/05/2020 amounted to 63 043 829 760 US dollars. 15/05/2020 Regeneron Pharmaceuticals, Inc. market capitalization is equal to 64 893 685 760 US dollars. Regeneron Pharmaceuticals, Inc. market capitalization is $ 64 110 534 656 at 14/05/2020.

Regeneron Pharmaceuticals, Inc. capitalization is 63 916 994 560 $ now. Market capitalization of Regeneron Pharmaceuticals, Inc. changed by +1.26% since yesterday. Today's volume of trade of REGN stocks was 339 909 $. REGN volume of trade amount changed to -58.178% since yesterday.

Regeneron Pharmaceuticals, Inc. stocks data

Regeneron Pharmaceuticals, Inc. financials